Guardant Health Hopes Lung Cancer Stakeholder Alignment Will Help Advance Liquid Biopsy Goals - GenomeWeb
Guardant Health Hopes Lung Cancer Stakeholder Alignment Will Help Advance Liquid Biopsy Goals GenomeWeb
The firm has joined forces with AstraZeneca, the IASLC, and the Global Lung Cancer Coalition, with a goal to double five-year survival rates by 2025.
Comments
Post a Comment